Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-20 4:50 pm Sale | 2026-05-05 | 13G | ERNEXA THERAPEUTICS INC P ERNA | Clear Street LLC | 0 0.000% | -149,499 (Position Closed) | Filing History |
| 2026-05-15 8:54 pm Sale | 2026-02-10 | 13G | ERNEXA THERAPEUTICS INC P ERNA | Freebird Partners LP | 120,412 9.900% | -665,628 (-84.68%) | Filing History |
| 2026-05-15 8:50 pm Sale | 2026-02-10 | 13G | ERNEXA THERAPEUTICS INC P ERNA | John D. Halpern | 66,751 5.600% | -331,371 (-83.23%) | Filing History |
| 2026-05-14 5:45 pm Purchase | 2026-03-31 | 13G | ERNEXA THERAPEUTICS INC ERNA | Bleichroeder LP | 80,000 6.860% | 80,000 (New Position) | Filing History |
| 2026-05-14 12:31 pm Purchase | 2026-05-05 | 13G | ERNEXA THERAPEUTICS INC P ERNA | Clear Street LLC | 149,499 12.800% | 149,499 (New Position) | Filing History |
| 2026-05-13 9:49 pm Sale | 2026-02-10 | 13G | ERNEXA THERAPEUTICS INC P ERNA | Konar Shameek | 118,342 9.700% | -440,189 (-78.81%) | Filing History |
| 2026-02-17 9:26 pm Purchase | 2026-02-10 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 431,653 34.700% | 320,478 (+288.26%) | Filing History |
| 2025-12-19 3:50 pm Purchase | 2025-12-19 | 13G | ERNEXA THERAPEUTICS INC ERNA | Freebird Partners LP | 31,442 9.900% | 14,878 (+89.82%) | Filing History |
| 2025-12-16 5:42 pm Purchase | 2025-06-30 | 13G | ERNEXA THERAPEUTICS INC ERNA | Konar Shameek | 22,341 7.120% | 13,180 (+143.87%) | Filing History |
| 2025-08-18 4:05 pm Purchase | 2025-07-28 | 13G | ERNEXA THERAPEUTICS INC ERNA | IAF, LLC | 12,631 4.100% | 3,950 (+45.50%) | Filing History |
| 2025-06-11 8:39 pm Purchase | 2025-06-09 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 111,175 37.900% | 56,688 (+104.04%) | Filing History |
| 2025-05-15 9:13 pm Purchase | 2025-03-31 | 13G | ERNEXA THERAPEUTICS INC ERNA | John D. Halpern | 15,925 9.600% | 2,227 (+16.26%) | Filing History |
| 2025-05-15 4:42 pm Purchase | 2025-03-31 | 13G | ERNEXA THERAPEUTICS INC ERNA | Konar Shameek | 9,161 5.500% | 9,161 (New Position) | Filing History |
| 2025-05-14 8:39 pm Purchase | 2025-03-31 | 13G | ERNEXA THERAPEUTICS INC ERNA | IAF, LLC | 8,681 5.200% | 1,536 (+21.50%) | Filing History |
| 2025-05-14 2:14 pm Purchase | 2025-03-31 | 13G | ERNEXA THERAPEUTICS INC ERNA | Freebird Partners LP | 16,564 9.900% | 2,866 (+20.92%) | Filing History |
| 2025-04-04 10:55 am Purchase | 2025-04-02 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 54,487 32.800% | 10,108 (+22.78%) | Filing History |
| 2025-03-05 5:55 pm Purchase | 2024-10-29 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 44,379 32.380% | 41,146 (+1272.69%) | Filing History |
| 2025-02-14 9:30 pm Purchase | 2024-12-31 | 13G | ERNEXA THERAPEUTICS INC ERNA | Nicholas Jason Singer | 6,840 4.920% | 5,239 (+327.23%) | Filing History |
| 2025-02-14 8:36 pm Purchase | 2024-10-29 | 13G | ERNEXA THERAPEUTICS INC ERNA | John D. Halpern | 13,698 9.990% | 12,229 (+832.47%) | Filing History |
| 2025-02-12 5:54 pm Purchase | 2024-10-29 | 13G | ERNEXA THERAPEUTICS INC ERNA | IAF, LLC | 7,145 5.220% | 5,606 (+364.26%) | Filing History |